Meric-Bernstam F - Search Results

1

Phase I, first-in-human study of futibatinib, a highly selective, irreversible FGFR1-4 inhibitor in patients with advanced solid tumors.

Bahleda R, Meric-Bernstam F, Goyal L, Tran B, He Y, Yamamiya I, Benhadji KA, Matos I, Arkenau HT. Bahleda R, et al. Ann Oncol. 2020 Oct;31(10):1405-1412. doi: 10.1016/j.annonc.2020.06.018. Epub 2020 Jul 2. Ann Oncol. 2020. PMID: 32622884 Free PMC article. Clinical Trial.

2

Efficacy of RAD001 (everolimus) and octreotide LAR in advanced low- to intermediate-grade neuroendocrine tumors: results of a phase II study.

Yao JC, Phan AT, Chang DZ, Wolff RA, Hess K, Gupta S, Jacobs C, Mares JE, Landgraf AN, Rashid A, Meric-Bernstam F. Yao JC, et al. J Clin Oncol. 2008 Sep 10;26(26):4311-8. doi: 10.1200/JCO.2008.16.7858. J Clin Oncol. 2008. PMID: 18779618 Free PMC article. Clinical Trial.

3

Chemokine receptors in advanced breast cancer: differential expression in metastatic disease sites with diagnostic and therapeutic implications.

Cabioglu N, Sahin AA, Morandi P, Meric-Bernstam F, Islam R, Lin HY, Bucana CD, Gonzalez-Angulo AM, Hortobagyi GN, Cristofanilli M. Cabioglu N, et al. Ann Oncol. 2009 Jun;20(6):1013-9. doi: 10.1093/annonc/mdn740. Epub 2009 Feb 23. Ann Oncol. 2009. PMID: 19237480 Free PMC article.

4

Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer.

Liedtke C, Broglio K, Moulder S, Hsu L, Kau SW, Symmans WF, Albarracin C, Meric-Bernstam F, Woodward W, Theriault RL, Kiesel L, Hortobagyi GN, Pusztai L, Gonzalez-Angulo AM. Liedtke C, et al. Ann Oncol. 2009 Dec;20(12):1953-8. doi: 10.1093/annonc/mdp263. Epub 2009 Jul 12. Ann Oncol. 2009. PMID: 19596702 Free PMC article.

5

A phase 1 dose escalation, pharmacokinetic, and pharmacodynamic evaluation of eIF-4E antisense oligonucleotide LY2275796 in patients with advanced cancer.

Hong DS, Kurzrock R, Oh Y, Wheler J, Naing A, Brail L, Callies S, André V, Kadam SK, Nasir A, Holzer TR, Meric-Bernstam F, Fishman M, Simon G. Hong DS, et al. Clin Cancer Res. 2011 Oct 15;17(20):6582-91. doi: 10.1158/1078-0432.CCR-11-0430. Epub 2011 Aug 10. Clin Cancer Res. 2011. PMID: 21831956 Free PMC article. Clinical Trial.

6

Functional proteomics characterization of residual breast cancer after neoadjuvant systemic chemotherapy.

Gonzalez-Angulo AM, Liu S, Chen H, Chavez-Macgregor M, Sahin A, Hortobagyi GN, Mills GB, Do KA, Meric-Bernstam F. Gonzalez-Angulo AM, et al. Ann Oncol. 2013 Apr;24(4):909-16. doi: 10.1093/annonc/mds530. Epub 2012 Nov 8. Ann Oncol. 2013. PMID: 23139263 Free PMC article.

7

Pathologic complete response to neoadjuvant chemotherapy with trastuzumab predicts for improved survival in women with HER2-overexpressing breast cancer.

Kim MM, Allen P, Gonzalez-Angulo AM, Woodward WA, Meric-Bernstam F, Buzdar AU, Hunt KK, Kuerer HM, Litton JK, Hortobagyi GN, Buchholz TA, Mittendorf EA. Kim MM, et al. Ann Oncol. 2013 Aug;24(8):1999-2004. doi: 10.1093/annonc/mdt131. Epub 2013 Apr 5. Ann Oncol. 2013. PMID: 23562929 Free PMC article.

8

Functional proteomics characterization of residual triple-negative breast cancer after standard neoadjuvant chemotherapy.

Sohn J, Do KA, Liu S, Chen H, Mills GB, Hortobagyi GN, Meric-Bernstam F, Gonzalez-Angulo AM. Sohn J, et al. Ann Oncol. 2013 Oct;24(10):2522-2526. doi: 10.1093/annonc/mdt248. Epub 2013 Aug 7. Ann Oncol. 2013. PMID: 23925999 Free PMC article.

9

Weekly nab-Rapamycin in patients with advanced nonhematologic malignancies: final results of a phase I trial.

Gonzalez-Angulo AM, Meric-Bernstam F, Chawla S, Falchook G, Hong D, Akcakanat A, Chen H, Naing A, Fu S, Wheler J, Moulder S, Helgason T, Li S, Elias I, Desai N, Kurzrock R. Gonzalez-Angulo AM, et al. Clin Cancer Res. 2013 Oct 1;19(19):5474-84. doi: 10.1158/1078-0432.CCR-12-3110. Clin Cancer Res. 2013. PMID: 24089446 Free PMC article. Clinical Trial.

10

Which threshold for ER positivity? a retrospective study based on 9639 patients.

Yi M, Huo L, Koenig KB, Mittendorf EA, Meric-Bernstam F, Kuerer HM, Bedrosian I, Buzdar AU, Symmans WF, Crow JR, Bender M, Shah RR, Hortobagyi GN, Hunt KK. Yi M, et al. Ann Oncol. 2014 May;25(5):1004-11. doi: 10.1093/annonc/mdu053. Epub 2014 Feb 20. Ann Oncol. 2014. PMID: 24562447 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

675 results

Search Page